1. Home
  2. CCEL vs VIVK Comparison

CCEL vs VIVK Comparison

Compare CCEL & VIVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCEL
  • VIVK
  • Stock Information
  • Founded
  • CCEL 1989
  • VIVK 2006
  • Country
  • CCEL United States
  • VIVK United States
  • Employees
  • CCEL N/A
  • VIVK N/A
  • Industry
  • CCEL Managed Health Care
  • VIVK Oilfield Services/Equipment
  • Sector
  • CCEL Health Care
  • VIVK Energy
  • Exchange
  • CCEL Nasdaq
  • VIVK Nasdaq
  • Market Cap
  • CCEL 50.0M
  • VIVK 43.8M
  • IPO Year
  • CCEL 1997
  • VIVK N/A
  • Fundamental
  • Price
  • CCEL $7.80
  • VIVK $1.18
  • Analyst Decision
  • CCEL
  • VIVK
  • Analyst Count
  • CCEL 0
  • VIVK 0
  • Target Price
  • CCEL N/A
  • VIVK N/A
  • AVG Volume (30 Days)
  • CCEL 13.9K
  • VIVK 20.7K
  • Earning Date
  • CCEL 12-24-2024
  • VIVK 11-19-2024
  • Dividend Yield
  • CCEL 3.14%
  • VIVK N/A
  • EPS Growth
  • CCEL N/A
  • VIVK N/A
  • EPS
  • CCEL N/A
  • VIVK N/A
  • Revenue
  • CCEL $31,838,476.00
  • VIVK $61,991,772.00
  • Revenue This Year
  • CCEL $3.97
  • VIVK N/A
  • Revenue Next Year
  • CCEL $0.91
  • VIVK N/A
  • P/E Ratio
  • CCEL N/A
  • VIVK N/A
  • Revenue Growth
  • CCEL 1.95
  • VIVK 0.33
  • 52 Week Low
  • CCEL $4.47
  • VIVK $0.67
  • 52 Week High
  • CCEL $9.50
  • VIVK $3.45
  • Technical
  • Relative Strength Index (RSI)
  • CCEL 45.13
  • VIVK 31.56
  • Support Level
  • CCEL $7.60
  • VIVK $1.15
  • Resistance Level
  • CCEL $9.10
  • VIVK $1.50
  • Average True Range (ATR)
  • CCEL 0.27
  • VIVK 0.12
  • MACD
  • CCEL -0.15
  • VIVK -0.03
  • Stochastic Oscillator
  • CCEL 23.61
  • VIVK 14.59

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.

About VIVK Vivakor Inc.

Vivakor Inc is a socially responsible operator, acquirer and developer of technologies and assets in the oil and gas industry, as well as related environmental solutions. It is primarily focused on operating crude oil gathering, storage and transportation facilities, as well as contaminated soil remediation services.

Share on Social Networks: